Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort ascending
Jul
3
2019
Privacy Tip #197 — Medtronic 508 (MiniMed) Insulin Pumps Recalled Robinson & Cole LLP
Oct
25
2022
Advisory Opinion 22-19: OIG Warns That Proposed Drug Cost Subsidization Arrangement May Warrant Sanctions Robinson & Cole LLP
Mar
25
2020
COVID-19 Vaccine Test Lab Hit by Maze Ransomware Robinson & Cole LLP
Apr
9
2020
Massachusetts Issues COVID-19 Orders and Guidance for Providers Robinson & Cole LLP
Apr
30
2020
ExecuPharm Data Stolen in Ransomware Attack Published on Internet Robinson & Cole LLP
Feb
8
2019
Genetic Testing Comes at a Cost Robinson & Cole LLP
May
25
2022
Connecticut Makes Significant Changes to its Collaborative Drug Therapy Laws Robinson & Cole LLP
Jan
29
2020
DOJ Announces Settlement with EHR Company to Resolve Criminal and Civil Kickback Investigations Tied to Opioid Prescribing Robinson & Cole LLP
Feb
6
2020
30,000 Cannabis Users’ Data Exposed Robinson & Cole LLP
Mar
17
2020
Massachusetts Issues COVID-19 Guidance for Health Care Providers, Payors and Laboratories on Issues Including Telehealth, Elective Procedures, COVID-19 Testing, and Expedited Provider Licensure Robinson & Cole LLP
Jul
9
2019
Federal Judge Vacates Final Rule on Drug Pricing Transparency in Consumer Advertising Robinson & Cole LLP
Aug
15
2019
Allscripts Announces $145 Million Preliminary Settlement with DOJ Related to an Investigation of Practice Fusion, a Recently Acquired EHR Company Robinson & Cole LLP
Nov
10
2022
California Bans the Manufacture and Sale of Certain PFAS-Containing Products Robinson & Cole LLP
Jul
12
2023
Connecticut Places Checks on PBM Contracts in Support of 340B Covered Entities Robinson & Cole LLP
Jul
16
2020
Reinventing Supply Chains to Reach Patients in Remote Areas Robinson & Cole LLP
Aug
18
2021
Connecticut’s Recreational Marijuana Law And Its Impact on the Workplace Robinson & Cole LLP
Feb
22
2022
Delaware District Court Determines that HRSA Enforcement Letter Targeting 340B Program Restrictions Violates the APA Robinson & Cole LLP
Jun
26
2019
DOJ Enters into $225 Million Settlement with Opioid Manufacturer to Resolve Criminal and Civil Investigations Robinson & Cole LLP
Oct
7
2019
CMS Passes Final Rule Reducing Regulations Burdensome on Health Care Providers Robinson & Cole LLP
Oct
24
2019
Manufacturers are Not Immune to Claims that their Inventions are Patent-Ineligible Robinson & Cole LLP
Nov
7
2019
Medical Prescription Delivered by Drone Robinson & Cole LLP
Nov
24
2021
Court Denies GrubHub’s Motion to Dismiss in TCPA Class Action Robinson & Cole LLP
May
12
2022
U.S. Agricultural Machinery Manufacturer Hit with Ransomware Attack Robinson & Cole LLP
Oct
3
2019
Privacy Tip #210 – HHS Office of Inspector General Issues Fraud Alert for Genetic Testing Scam Targeting Seniors Robinson & Cole LLP
Jun
16
2023
Privacy Tip #364 – Montana Enacts Genetic Information Privacy Law Robinson & Cole LLP
Sep
21
2023
Joint Advisory Warns of Snatch Ransomware Robinson & Cole LLP
Apr
15
2021
The Endless Frontier Act: Shifting the Focus from Defense to Offense Robinson & Cole LLP
Dec
14
2021
CMS Issues Memorandum Stating It Will Not Enforce Its COVID-19 Vaccine Mandate While There are Court-Ordered Injunctions in Place Robinson & Cole LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins